ClinicalTrials.Veeva

Find clinical trials for Breast Cancer in Austin, TX

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Carcinoma
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer
Non-Small-Cell Lung Carcinoma
Lung Cancer

Breast Cancer trials near Austin, TX, USA:

ARX788 in HER2-positive, Metastatic Breast Cancer Subjects (ACE-Breast-03)

A Global, Phase 2 Study of ARX788 in HER2-positive Metastatic Breast Cancer Patients who were previously treated with T-DXd...

Enrolling
HER2 Positive Metastatic Breast Cancer
Drug: ARX788

Phase 2

Ambrx

Austin, Texas, United States and 57 other locations

ovarian function in premenopausal women with HR+, HER2-negative breast cancer and men with HR+ breast cancer. The...

Invitation-only
Breast Cancer
Drug: TOL2506
Drug: Letrozole tablets

Phase 3

Tolmar Pharmaceuticals

New Braunfels, Texas, United States and 10 other locations

RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer...

Active, not recruiting
Breast Cancer
Drug: Letrozole
Other: Placebo

Phase 3

National Surgical Adjuvant Breast and Bowel Project Foundation (NSABP)

Austin, Texas, United States and 805 other locations

growth factor receptor (HER)2-low, hormone receptor (HR) positive breast cancer patients whose disease has progressed on endocrine ...

Active, not recruiting
Advanced or Metastatic Breast Cancer
Drug: Nab-Paclitaxel
Drug: Trastuzumab deruxtecan

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 293 other locations

in patients with advanced solid tumors or in combination with anti-cancer agents such as CDK 4/6 inhibitor palbociclib in patients with ER+/ ...

Enrolling
Breast Cancer
Solid Tumor, Adult
Drug: Palbociclib
Drug: APG-2575

Phase 1, Phase 2

Ascentage Pharma Group
Ascentage Pharma Group

Austin, Texas, United States and 3 other locations

adjuvant endocrine therapy for patients with ER+/HER2- early breast cancer with intermediate-high or high risk for disease recurren...

Enrolling
Breast Cancer, Early Breast Cancer
Drug: Letrozole
Drug: Exemestane

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 464 other locations

This is a Phase 3, multicenter, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of trilaciclib versus placebo a...

Active, not recruiting
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Drug: Trilaciclib
Drug: Placebo

Phase 3

G1 Therapeutics

Austin, Texas, United States and 70 other locations

treatment of patients with locally advanced or metastatic HR+/HER2- breast cancer following progression on or after CDK4/6 and arom...

Enrolling
Breast Cancer
Drug: Alpelisib
Drug: Fulvestrant

Phase 3

Celcuity

Austin, Texas, United States and 217 other locations

Locations recently updated

receptor-low/HER2-negative breast cancer....

Enrolling
Breast Cancer
Drug: Carboplatin
Drug: Olaparib

Phase 3

AstraZeneca
AstraZeneca

Austin, Texas, United States and 331 other locations

with unresectable, locally advanced or metastatic triple-negative breast cancer (TNBC) who received at least 2 prior treatments, at...

Active, not recruiting
Triple Negative Breast Cancer
Drug: Sacituzumab Govitecan-hziy
Drug: Trilaciclib

Phase 2

G1 Therapeutics

Austin, Texas, United States and 21 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems